-
1
Backtranslation of human RNA biosignatures of tuberculosis disease risk into the preclinical pipeline is condition dependent
Published 2025-01-01Subjects: Get full text
Article -
2
Integration of histone modification-based risk signature with drug sensitivity analysis reveals novel therapeutic strategies for lower-grade glioma
Published 2025-01-01Subjects: Get full text
Article -
3
Prognostic model and immune-infiltrating cell landscape based on differentially expressed autophagy-related genes in TP53-mutated multiple myeloma
Published 2021-07-01Subjects: Get full text
Article